Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency

Cell Stem Cell

Volumn 14, Issue 5, 2014, Pages 592-605

  Mathieu, Julie ^a   Zhou, Wenyu ^a,b   Xing, Yalan ^a   Sperber, Henrik ^a,b   Ferreccio, Amy ^a   Agoston, Zsuzsa ^a   Kuppusamy, Kavitha T ^a   Moon, Randall T ^a,b   Ruohola Baker, Hannele ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HIF1A PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UPREGULATION; ACIDIFICATION; AEROBIC METABOLISM; CONTROLLED STUDY; GENE EXPRESSION; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; PROTEOMICS; CELL CULTURE; CYTOLOGY; FIBROBLAST; GENETICS; METABOLISM; PHYSIOLOGY; TIME;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASPASE 3; CELLS, CULTURED; CELLULAR REPROGRAMMING; EMBRYONIC STEM CELLS; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDUCED PLURIPOTENT STEM CELLS; RNA, SMALL INTERFERING; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84899919010     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2014.02.012     Document Type: Article

References (72)

1. L. Armstrong, K. Tilgner, G. Saretzki, S.P. Atkinson, M. Stojkovic, R. Moreno, S. Przyborski, and M. Lako Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells Stem Cells 28 2010 661 673
2. H. Axelson, E. Fredlund, M. Ovenberger, G. Landberg, and S. Påhlman Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors Semin. Cell Dev. Biol. 16 2005 554 563
3. S.M. Cabarcas, L.A. Mathews, and W.L. Farrar The cancer stem cell niche - there goes the neighborhood? Int. J. Cancer 129 2011 2315 2327
4. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat. Rev. Cancer 11 2011 85 95
5. V. Compernolle, K. Brusselmans, T. Acker, P. Hoet, M. Tjwa, H. Beck, S. Plaisance, Y. Dor, E. Keshet, and F. Lupu et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice Nat. Med. 8 2002 702 710
6. K.L. Covello, J. Kehler, H. Yu, J.D. Gordan, A.M. Arsham, C.J. Hu, P.A. Labosky, M.C. Simon, and B. Keith HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes Dev. 20 2006 557 570
7. G.H. Danet, Y. Pan, J.L. Luongo, D.A. Bonnet, and M.C. Simon Expansion of human SCID-repopulating cells under hypoxic conditions J. Clin. Invest. 112 2003 126 135
8. B. Das, R. Bayat-Mokhtari, M. Tsui, S. Lotfi, R. Tsuchida, D.W. Felsher, and H. Yeger HIF-2α suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells Stem Cells 30 2012 1685 1695
9. M.A. Degli-Esposti, W.C. Dougall, P.J. Smolak, J.Y. Waugh, C.A. Smith, and R.G. Goodwin The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 1997 813 820
10. S.L. Dunwoodie The role of hypoxia in development of the Mammalian embryo Dev. Cell 17 2009 755 773
11. H. Ehrhardt, S. Fulda, I. Schmid, J. Hiscott, K.M. Debatin, and I. Jeremias TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB Oncogene 22 2003 3842 3852
12. T. Ezashi, P. Das, and R.M. Roberts Low O2 tensions and the prevention of differentiation of hES cells Proc. Natl. Acad. Sci. USA 102 2005 4783 4788
13. C.D. Folmes, T.J. Nelson, A. Martinez-Fernandez, D.K. Arrell, J.Z. Lindor, P.P. Dzeja, Y. Ikeda, C. Perez-Terzic, and A. Terzic Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming Cell Metab. 14 2011 264 271
14. A. Franovic, C.E. Holterman, J. Payette, and S. Lee Human cancers converge at the HIF-2alpha oncogenic axis Proc. Natl. Acad. Sci. USA 106 2009 21306 21311
15. R.A. Goldsby, and P.G. Heytler Uncoupling of Oxidative Phosphorylation by Carbonyl Cyanide Phenylhydrazones. Ii. Effects of Carbonyl Cyanide M-Chlorophenylhydrazone on Mitochondrial Respiration Biochemistry 2 1963 1142 1147
16. S.N. Greer, J.L. Metcalf, Y. Wang, and M. Ohh The updated biology of hypoxia-inducible factor EMBO J. 31 2012 2448 2460
17. J. Hansson, M.R. Rafiee, S. Reiland, J.M. Polo, J. Gehring, S. Okawa, W. Huber, K. Hochedlinger, and J. Krijgsveld Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency Cell Rep 2 2012 1579 1592
18. J.M. Heddleston, Z. Li, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
19. P.G. Heytler uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones. I. Some characteristics of m-Cl-CCP action on mitochondria and chloroplasts Biochemistry 2 1963 357 361
20. C.J. Hu, A. Sataur, L. Wang, H. Chen, and M.C. Simon The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha Mol. Biol. Cell 18 2007 4528 4542
21. M. Husa, R. Liu-Bryan, and R. Terkeltaub Shifting HIFs in osteoarthritis Nat. Med. 16 2010 641 644
22. N.V. Iyer, L.E. Kotch, F. Agani, S.W. Leung, E. Laughner, R.H. Wenger, M. Gassmann, J.D. Gearhart, A.M. Lawler, A.Y. Yu, and G.L. Semenza Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha Genes Dev. 12 1998 149 162
23. M. Kato, J. Li, J.L. Chuang, and D.T. Chuang Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol Structure 15 2007 992 1004
24. B. Keith, R.S. Johnson, and M.C. Simon HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression Nat. Rev. Cancer 12 2012 9 22
25. Y.S. Kim, R.F. Schwabe, T. Qian, J.J. Lemasters, and D.A. Brenner TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells Hepatology 36 2002 1498 1508
26. F.A. Kruyt, and J.J. Schuringa Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy Biochem. Pharmacol. 80 2010 423 430
27. L. Li, L. Zhang, X. Zhang, Q. Yan, Y.A. Minamishima, A.F. Olumi, M. Mao, S. Bartz, and W.G. Kaelin Jr. Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations Mol. Cell. Biol. 27 2007 5381 5392
28. Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, Q. Shi, Y. Cao, J. Lathia, and R.E. McLendon et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
29. F. Li, Z. He, J. Shen, Q. Huang, W. Li, X. Liu, Y. He, F. Wolf, and C.Y. Li Apoptotic caspases regulate induction of iPSCs from human fibroblasts Cell Stem Cell 7 2010 508 520
30. X. Liu, P. Yue, F.R. Khuri, and S.Y. Sun Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity Cancer Res. 65 2005 9169 9175
31. A. Loboda, A. Jozkowicz, and J. Dulak HIF-1 and HIF-2 transcription factors - similar but not identical Mol. Cells 29 2010 435 442
32. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, C.M. Pinna, A. Hubaud, B. Stadler, M. Choi, and M. Bar et al. HIF induces human embryonic stem cell markers in cancer cells Cancer Res. 71 2011 4640 4652
33. J. Mathieu, Z. Zhang, A. Nelson, D.A. Lamba, T.A. Reh, C. Ware, and H. Ruohola-Baker Hypoxia induces re-entry of committed cells into pluripotency Stem Cells 31 2013 1737 1748
34. D. Mérino, N. Lalaoui, A. Morizot, P. Schneider, E. Solary, and O. Micheau Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2 Mol. Cell. Biol. 26 2006 7046 7055
35. D. Mérino, N. Lalaoui, A. Morizot, E. Solary, and O. Micheau TRAIL in cancer therapy: present and future challenges Expert Opin. Ther. Targets 11 2007 1299 1314
36. A. Mohyeldin, T. Garzón-Muvdi, and A. Quiñones-Hinojosa Oxygen in stem cell biology: a critical component of the stem cell niche Cell Stem Cell 7 2010 150 161
37. S.J. Morrison, M. Csete, A.K. Groves, W. Melega, B. Wold, and D.J. Anderson Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells J. Neurosci. 20 2000 7370 7376
38. S.M. Nemetski, and L.B. Gardner Hypoxic regulation of Id-1 and activation of the unfolded protein response are aberrant in neuroblastoma J. Biol. Chem. 282 2007 240 248
39. A.D. Panopoulos, S. Ruiz, F. Yi, A. Herrerías, E.M. Batchelder, and J.C. Izpisua Belmonte Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells PLoS ONE 6 2011 e19743
40. A.D. Panopoulos, O. Yanes, S. Ruiz, Y.S. Kida, D. Diep, R. Tautenhahn, A. Herrerías, E.M. Batchelder, N. Plongthongkum, and M. Lutz et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming Cell Res. 22 2012 168 177
41. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
42. J.M. Polo, E. Anderssen, R.M. Walsh, B.A. Schwarz, C.M. Nefzger, S.M. Lim, M. Borkent, E. Apostolou, S. Alaei, and J. Cloutier et al. A molecular roadmap of reprogramming somatic cells into iPS cells Cell 151 2012 1617 1632
43. J. Pouysségur, F. Dayan, and N.M. Mazure Hypoxia signalling in cancer and approaches to enforce tumour regression Nature 441 2006 437 443
44. A. Prigione, and J. Adjaye Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells Int. J. Dev. Biol. 54 2010 1729 1741
45. A. Prigione, B. Fauler, R. Lurz, H. Lehrach, and J. Adjaye The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells Stem Cells 28 2010 721 733
46. A. Prigione, N. Rohwer, S. Hoffmann, B. Mlody, K. Drews, R. Bukowiecki, K. Blümlein, E.E. Wanker, M. Ralser, T. Cramer, and J. Adjaye HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2 Stem Cells 32 2014 364 376
47. V.A. Rafalski, E. Mancini, and A. Brunet Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate J. Cell Sci. 125 2012 5597 5608
48. H.E. Ryan, J. Lo, and R.S. Johnson HIF-1 alpha is required for solid tumor formation and embryonic vascularization EMBO J. 17 1998 3005 3015
49. A.D. Sanlioglu, E. Dirice, C. Aydin, N. Erin, S. Koksoy, and S. Sanlioglu Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells BMC Cancer 5 2005 54
50. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
51. T. Simsek, F. Kocabas, J. Zheng, R.J. Deberardinis, A.I. Mahmoud, E.N. Olson, J.W. Schneider, C.C. Zhang, and H.A. Sadek The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche Cell Stem Cell 7 2010 380 390
52. B. Stadler, I. Ivanovska, K. Mehta, S. Song, A. Nelson, Y. Tan, J. Mathieu, C. Darby, C.A. Blau, and C. Ware et al. Characterization of microRNAs involved in embryonic stem cell states Stem Cells Dev. 19 2010 935 950
53. L. Studer, M. Csete, S.H. Lee, N. Kabbani, J. Walikonis, B. Wold, and R. McKay Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J. Neurosci. 20 2000 7377 7383
54. T. Suda, K. Takubo, and G.L. Semenza Metabolic regulation of hematopoietic stem cells in the hypoxic niche Cell Stem Cell 9 2011 298 310
55. S.T. Suhr, E.A. Chang, J. Tjong, N. Alcasid, G.A. Perkins, M.D. Goissis, M.H. Ellisman, G.I. Perez, and J.B. Cibelli Mitochondrial rejuvenation after induced pluripotency PLoS ONE 5 2010 e14095
56. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
57. K. Takubo, and T. Suda Roles of the hypoxia response system in hematopoietic and leukemic stem cells Int. J. Hematol. 95 2012 478 483
58. K. Takubo, N. Goda, W. Yamada, H. Iriuchishima, E. Ikeda, Y. Kubota, H. Shima, R.S. Johnson, A. Hirao, M. Suematsu, and T. Suda Regulation of the HIF-1alpha level is essential for hematopoietic stem cells Cell Stem Cell 7 2010 391 402
59. S. Varum, A.S. Rodrigues, M.B. Moura, O. Momcilovic, C.A. Easley 4th, J. Ramalho-Santos, B. Van Houten, and G. Schatten Energy metabolism in human pluripotent stem cells and their differentiated counterparts PLoS ONE 6 2011 e20914
60. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, and T. Le et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157 163
61. Y. Wang, Y. Liu, S.N. Malek, P. Zheng, and Y. Liu Targeting HIF1α eliminates cancer stem cells in hematological malignancies Cell Stem Cell 8 2011 399 411
62. C.B. Ware, A.M. Nelson, and C.A. Blau A comparison of NIH-approved human ESC lines Stem Cells 24 2006 2677 2684
63. X. Xia, Y. Zhang, C.R. Zieth, and S.C. Zhang Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner Stem Cells Dev. 16 2007 167 176
64. Q. Yan, S. Bartz, M. Mao, L. Li, and W.G. Kaelin Jr. The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo Mol. Cell. Biol. 27 2007 2092 2102
65. O. Yanes, J. Clark, D.M. Wong, G.J. Patti, A. Sánchez-Ruiz, H.P. Benton, S.A. Trauger, C. Desponts, S. Ding, and G. Siuzdak Metabolic oxidation regulates embryonic stem cell differentiation Nat. Chem. Biol. 6 2010 411 417
66. Y. Yoshida, K. Takahashi, K. Okita, T. Ichisaka, and S. Yamanaka Hypoxia enhances the generation of induced pluripotent stem cells Cell Stem Cell 5 2009 237 241
67. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, and R. Stewart et al. Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
68. J. Yu, K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I.I. Slukvin, and J.A. Thomson Human induced pluripotent stem cells free of vector and transgene sequences Science 324 2009 797 801
69. J. Zhang, I. Khvorostov, J.S. Hong, Y. Oktay, L. Vergnes, E. Nuebel, P.N. Wahjudi, K. Setoguchi, G. Wang, and A. Do et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells EMBO J. 30 2011 4860 4873
70. W. Zhou, T.L. Dosey, T. Biechele, R.T. Moon, M.S. Horwitz, and H. Ruohola-Baker Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct PLoS ONE 6 2011 e27460
71. W. Zhou, M. Choi, D. Margineantu, L. Margaretha, J. Hesson, C. Cavanaugh, C.A. Blau, M.S. Horwitz, D. Hockenbery, C. Ware, and H. Ruohola-Baker HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition EMBO J. 31 2012 2103 2116
72. S. Zhu, W. Li, H. Zhou, W. Wei, R. Ambasudhan, T. Lin, J. Kim, K. Zhang, and S. Ding Reprogramming of human primary somatic cells by OCT4 and chemical compounds Cell Stem Cell 7 2010 651 655